The autoimmune diagnostic company expects its new assay to be available by the end of this year or in early 2027.

T cells are central mediators of autoimmune disease pathogenesis, yet their functional states are not defined solely by antigen recognition or canonical ...

People with from spinal cord injuries often lose some or all their limb function. In most patients, the nerves in their limbs work fine, and the neurons in their brain are still operational, but the ...

Novartis received breakthrough therapy designation from the FDA for ianalumab, a monoclonal antibody aimed at treating Sjögren’s disease. Ianalumab works by depleting B cells and blocking BAFF-R ...

Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...